In this respect, we evaluated the long-term effect of PRM and LCM, administered singly in a high-dose or in a low-dose combination of both on comorbid anxiety, cognitive impairment, BDNF, and Cyclin D1 hippocampal expression in an experimental model of TLE. The gene discussed is CCND1; the disease is Cognitive impairment.